Brief: Spago Nanomedical: Interim Results From Study On SpagoPix Show Clear Contrast In MR-Images

Spago Nanomedical AB (publ)

12/11/2020 09:13

Nov 12 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.TE :
    * INTERIM RESULT FROM PHASE I-STUDIEN SPAGOPIX-01 SHOWS THAT
SN132D PROVIDES CLEAR CONTRAST IN MR-IMAGES OF BREAST TUMORS
    * THIS INDICATES THAT SN132D CAN HELP WITH INVESTIGATING AND
MONITORING SUSPECTED AND DIAGNOSED BREAST CANCER WITH MRI

Source text for Eikon:  ID:nWkr8ql5c2 
Further company coverage:  SPAGO.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))